Benzoyl peroxide
This medicine should always be used exactly as described in the patient leaflet or as directed by a doctor or pharmacist.
Benzacne is a gel medicine with anti-acne action, intended for local application to the skin.
The medicine contains the active substance benzoyl peroxide. Benzoyl peroxide, when applied to the skin, easily penetrates the stratum corneum and inhibits the growth of anaerobic bacteria Propionibacterium acnes, which are one of the causes of common acne.
It also has a peeling effect on the skin, reducing the number of comedones.
Benzacne is indicated for the treatment of various forms of common acne (Acne vulgaris).
Before starting to use Benzacne, discuss it with your doctor or pharmacist.
Tell your doctor or pharmacist about all medicines you are taking, have recently taken, or plan to take.
Concurrent use of Benzacne with:
In case of necessity to use any other medicines at the same time, consult your doctor to determine possible changes in the use of Benzacne.
Do not use in children under 12 years of age.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
Do not apply the medicine to the breast area during breastfeeding.
Benzacne does not affect the ability to drive and use machines.
This medicine should always be used exactly as described in the patient leaflet or as directed by a doctor or pharmacist. If you are unsure, consult your doctor or pharmacist.
Recommended dose
Adults and children over 12 years old
Apply once or twice a day.
Usually, within the first 2 to 3 weeks of treatment, a medicine with a benzoyl peroxide content of 50 mg/g is used, and if necessary, treatment is continued with a medicine with a benzoyl peroxide content of 100 mg/g.
Method of administration
The medicine is intended for local application to the skin.
After washing and drying the skin, apply a small amount of the medicine to the affected areas and gently rub it in.
After applying the medicine, wash your hands.
If you feel that the effect of the medicine is too strong or too weak, consult your doctor.
A symptom of excessive use of Benzacne is redness or swelling of the skin. If they occur, stop using the medicine and contact your doctor.
Cold compresses can be applied to the irritated areas.
Do not use a double dose to make up for a missed dose.
Like all medicines, Benzacne can cause side effects, although not everybody gets them.
During treatment with Benzacne, the following may occur:
If the following symptoms occur, stop using the medicine and contact your doctor:
If you experience any side effects, including any side effects not listed in the leaflet, tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181 C, 02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Store the medicine at a temperature below 25°C. Do not freeze.
Store the medicine out of sight and reach of children.
Do not use this medicine after the expiry date stated on the tube and carton after EXP. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Benzacne is a white, odorless gel.
50 mg/g: The medicine is available in a tube containing 30 g of gel, placed in a cardboard box.
100 mg/g: The medicine is available in a tube containing 20 g of gel, placed in a cardboard box.
Orifarm Healthcare A/S
Energivej 15
5260 Odense S
Denmark
To obtain more detailed information about this medicine, contact the local representative of the marketing authorization holder:
Orifarm Healthcare Sp. z o.o.
ul. Przyokopowa 31
01-208 Warsaw
Poland
info-PL@orifarm.com
50 mg/g:
Orifarm Manufacturing Poland Sp. z o.o.
ul. Księstwa Łowickiego 12
99-420 Łyszkowice
Poland
100 mg/g:
Medinfar Manufacturing, S.A.
Parque Industrial Armando Martins Tavares,
Rua Outeiro da Armada, No 5,
Condeixa-a-Nova 3150-194
Portugal
Date of last update of the leaflet:08/2024
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.